Blood pressure medication recalled over trace amounts of cancer-causing chemical

Photo: U.S. Air Force / Pixbay
By  | 

CBS News - A drug manufacturer is voluntarily recalling some of its Valsartan blood pressure medication because of an ingredient that’s not intended to be in the product.

The Food and Drug Administration announced Aurobindo Pharma USA, Inc. is voluntarily recalling 80 lots of Amlodipine Valsartan Tablets, Valsartan HCTZ Tablets, and Valsartan Tablets. A full list of the recalled drugs and medication packaging can be found on the FDA website.

The impurity involves a chemical called N-nitrosodiethylamine (NDEA), which the FDA describes as a "substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes, and has been classified as a probable human carcinogen."

To date, the company says it has not received any reports of patients suffering adverse effects related to the recall.

The FDA recommends those who take the recalled drugs should not stop taking the medication, but should contact their pharmacist or doctor to set up an alternative treatment. Expiration dates range from May 2019 to March 2021.

“The risk of harm to the patient’s health may be higher if the treatment is stopped immediately without any alternative treatment,” said the FDA.

The company says it has not received any reports of adverse effects related to the recall.

To report an adverse event or to contact the drug manufacturer about questions regarding the recall, consumers should call 1-866-850-2876 and press option two or email pvg@aurobindousa.com.